Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-12-3
pubmed:abstractText
Schizophrenic patients demonstrate a variety of cognitive deficits, including attention, executive functions, and working memory, even in the early stage of disease. In the present study, we examined the association between blood levels of 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid (HVA), or brain-derived neurotrophic factor (BDNF) and scores on the Wisconsin Card Sorting Test (WCST) in patients with early-stage schizophrenia. We also investigated the association between frontal GABA levels using 1H-magnetic resonance spectroscopy (MRS) at 3T and scores on the WCST in the same patients. Blood levels of BDNF and catecholamine metabolites and brain GABA levels using 1H-MRS were measured in 18 schizophrenic patients (nine males, nine females; age range 13-52 year). A significantly positive correlation was observed between plasma MHPG levels and %PEM (rho = -0.686, p = 0.0047). A trend toward negative correlation was found between frontal lobe GABA levels and the per cent of preservation error (%PEM) in the early stage of schizophrenia (rho = -0.420, p = 0.0836). These results suggest that noradrenergic neurons might be involved in neuropsychological functions in early-stage of schizophrenia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1099-1077
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2009 John Wiley & Sons, Ltd.
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
639-45
pubmed:meshHeading
pubmed-meshheading:19946939-Adolescent, pubmed-meshheading:19946939-Adult, pubmed-meshheading:19946939-Antipsychotic Agents, pubmed-meshheading:19946939-Brain-Derived Neurotrophic Factor, pubmed-meshheading:19946939-Cognition Disorders, pubmed-meshheading:19946939-Female, pubmed-meshheading:19946939-Frontal Lobe, pubmed-meshheading:19946939-Homovanillic Acid, pubmed-meshheading:19946939-Humans, pubmed-meshheading:19946939-Magnetic Resonance Spectroscopy, pubmed-meshheading:19946939-Male, pubmed-meshheading:19946939-Methoxyhydroxyphenylglycol, pubmed-meshheading:19946939-Middle Aged, pubmed-meshheading:19946939-Neurons, pubmed-meshheading:19946939-Neuropsychological Tests, pubmed-meshheading:19946939-Norepinephrine, pubmed-meshheading:19946939-Schizophrenia, pubmed-meshheading:19946939-Young Adult, pubmed-meshheading:19946939-gamma-Aminobutyric Acid
pubmed:year
2009
pubmed:articleTitle
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
pubmed:affiliation
Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Japan.
pubmed:publicationType
Journal Article